• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长寿命 CD8(+) T 效应记忆细胞与异源初免-加强免疫接种诱导的保护性免疫的相关性。

Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.

机构信息

Centro de Terapia Celular e Molecular, Universidade Federal de São Paulo - Escola Paulista de Medicina São Paulo, São Paulo, Brazil ; Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina São Paulo, São Paulo, Brazil.

出版信息

Front Immunol. 2012 Dec 4;3:358. doi: 10.3389/fimmu.2012.00358. eCollection 2012.

DOI:10.3389/fimmu.2012.00358
PMID:23264773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3525016/
Abstract

Owing to the importance of major histocompatibility complex class Ia-restricted CD8(+) T cells for host survival following viral, bacterial, fungal, or parasitic infection, it has become largely accepted that these cells should be considered in the design of a new generation of vaccines. For the past 20 years, solid evidence has been provided that the heterologous prime-boost regimen achieves the best results in terms of induction of long-lived protective CD8(+) T cells against a variety of experimental infections. Although this regimen has often been used experimentally, as is the case for many vaccines, the mechanism behind the efficacy of this vaccination regimen is still largely unknown. The main purpose of this review is to examine the characteristics of the protective CD8(+) T cells generated by this vaccination regimen. Part of its efficacy certainly relies on the generation and maintenance of large numbers of specific lymphocytes. Other specific characteristics may also be important, and studies on this direction have only recently been initiated. So far, the characterization of these protective, long-lived T cell populations suggests that there is a high frequency of polyfunctional T cells; these cells cover a large breadth and display a T effector memory (TEM) phenotype. These TEM cells are capable of proliferating after an infectious challenge and are highly refractory to apoptosis due to a control of the expression of pro-apoptotic receptors such as CD95. Also, they do not undergo significant long-term immunological erosion. Understanding the mechanisms that control the generation and maintenance of the protective activity of these long-lived TEM cells will certainly provide important insights into the physiology of CD8(+) T cells and pave the way for the design of new or improved vaccines.

摘要

由于主要组织相容性复合体 I 类限制的 CD8(+) T 细胞对于宿主在病毒、细菌、真菌或寄生虫感染后的存活至关重要,因此人们普遍认为这些细胞应该在新一代疫苗的设计中得到考虑。在过去的 20 年中,已经提供了确凿的证据表明,异源初免-加强方案在诱导针对各种实验性感染的长寿命保护性 CD8(+) T 细胞方面取得了最佳效果。尽管这种方案经常在实验中使用,就像许多疫苗一样,但其疫苗接种方案有效性的机制在很大程度上仍然未知。本综述的主要目的是研究这种疫苗接种方案产生的保护性 CD8(+) T 细胞的特征。其部分功效当然依赖于大量特异性淋巴细胞的产生和维持。其他特定特征也可能很重要,并且最近才开始对此方向进行研究。到目前为止,这些保护性、长寿命 T 细胞群体的特征表明存在高频率的多功能 T 细胞;这些细胞覆盖了广泛的范围,并表现出 T 效应记忆(TEM)表型。这些 TEM 细胞在受到感染性挑战后能够增殖,并且由于控制了凋亡受体如 CD95 的表达,它们对凋亡具有高度抗性。此外,它们不会经历明显的长期免疫侵蚀。了解控制这些长寿命 TEM 细胞的保护性活性的产生和维持的机制,必将为 CD8(+) T 细胞的生理学提供重要的见解,并为设计新的或改进的疫苗铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd3/3525016/3dbb347d21f1/fimmu-03-00358-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd3/3525016/8884691f1791/fimmu-03-00358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd3/3525016/e0f5867ef38e/fimmu-03-00358-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd3/3525016/3dbb347d21f1/fimmu-03-00358-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd3/3525016/8884691f1791/fimmu-03-00358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd3/3525016/e0f5867ef38e/fimmu-03-00358-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd3/3525016/3dbb347d21f1/fimmu-03-00358-g003.jpg

相似文献

1
Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.长寿命 CD8(+) T 效应记忆细胞与异源初免-加强免疫接种诱导的保护性免疫的相关性。
Front Immunol. 2012 Dec 4;3:358. doi: 10.3389/fimmu.2012.00358. eCollection 2012.
2
Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.异源质粒 DNA 初免-重组人腺病毒 5 加强免疫接种可产生针对人体寄生虫克氏锥虫的保护性、长寿命 CD8(+)T 效应记忆细胞的稳定池。
Infect Immun. 2011 May;79(5):2120-30. doi: 10.1128/IAI.01190-10. Epub 2011 Feb 28.
3
Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.穿孔素和γ干扰素的表达是通过异源质粒DNA初免-重组腺病毒5加强疫苗接种引发的针对人类寄生虫克氏锥虫的CD4+和CD8+ T细胞依赖性保护性免疫所必需的。
Infect Immun. 2009 Oct;77(10):4383-95. doi: 10.1128/IAI.01459-08. Epub 2009 Aug 3.
4
Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.比较不同腺病毒载体诱导的猴免疫缺陷病毒 gag 特异性效应和记忆 CD8+T 细胞。
J Virol. 2013 Feb;87(3):1359-72. doi: 10.1128/JVI.02055-12. Epub 2012 Nov 21.
5
CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.由佐剂亚单位疫苗、腺病毒载体疫苗或异源初免-加强疫苗接种所促进的针对结核分枝杆菌Ag85B-TB10.4的CD4和CD8 T细胞应答。
PLoS One. 2009;4(4):e5139. doi: 10.1371/journal.pone.0005139. Epub 2009 Apr 9.
6
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.病毒样疫苗对抗 HIV/SIV 与亚优势抗原 T 细胞疫苗具有协同作用。
J Transl Med. 2019 May 24;17(1):175. doi: 10.1186/s12967-019-1924-1.
7
Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.使用基于多价修饰安卡拉疫苗病毒并以白细胞介素-15作为分子佐剂的高效持久抗结核初免/加强免疫方案。
Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.
8
Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.使用重组黑猩猩腺病毒载体和佐剂化F4蛋白的异源初免-加强免疫方案在猕猴中引发多功能HIV-1特异性T细胞反应。
PLoS One. 2015 Apr 9;10(4):e0122835. doi: 10.1371/journal.pone.0122835. eCollection 2015.
9
TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).TLR1/2 激活在异源初免-加强免疫接种(DNA-MVA)中增强 CD8+ T 细胞反应,提供针对利什曼原虫(Viannia)的保护。
PLoS Negl Trop Dis. 2011 Jun;5(6):e1204. doi: 10.1371/journal.pntd.0001204. Epub 2011 Jun 14.
10
Plasmodium berghei sporozoite challenge of vaccinated BALB/c mice leads to the induction of humoral immunity and improved function of CD8(+) memory T cells.伯氏疟原虫子孢子免疫接种 BALB/c 小鼠可诱导体液免疫和提高 CD8+记忆 T 细胞的功能。
Eur J Immunol. 2013 Mar;43(3):693-704. doi: 10.1002/eji.201142262. Epub 2013 Jan 18.

引用本文的文献

1
Advances in nucleic acid-based cancer vaccines.基于核酸的癌症疫苗的进展。
J Biomed Sci. 2025 Jan 21;32(1):10. doi: 10.1186/s12929-024-01102-w.
2
Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy.免疫调节纳米颗粒激活细胞毒性 T 细胞,增强癌症免疫疗法的效果。
Nanoscale. 2024 Oct 3;16(38):17699-17722. doi: 10.1039/d4nr01780c.
3
Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect.

本文引用的文献

1
The molecular signature of tissue resident memory CD8 T cells isolated from the brain.从大脑中分离出的组织驻留记忆 CD8 T 细胞的分子特征。
J Immunol. 2012 Oct 1;189(7):3462-71. doi: 10.4049/jimmunol.1201305. Epub 2012 Aug 24.
2
The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness.LGP2 样受体 RIG-I 控制 CD8(+)T 细胞的存活和适应性。
Immunity. 2012 Aug 24;37(2):235-48. doi: 10.1016/j.immuni.2012.07.004. Epub 2012 Jul 26.
3
Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.
基于肽的疫苗与病毒载体的异源初免-加强免疫接种重塑树突状细胞、CD4+和CD8+ T细胞表型以提高抗肿瘤治疗效果。
Cancers (Basel). 2021 Dec 3;13(23):6107. doi: 10.3390/cancers13236107.
4
Humoral Immune Response Evaluation in Horses Vaccinated with Recombinant Toxoids Alpha and Beta for 12 Months.12 个月龄马匹接种重组α和β类毒素后体液免疫应答评估。
Toxins (Basel). 2021 Aug 13;13(8):566. doi: 10.3390/toxins13080566.
5
Rapamycin Improves the Response of Effector and Memory CD8 T Cells Induced by Immunization With ASP2 of .雷帕霉素改善 ASP2 免疫诱导的效应器和记忆 CD8 T 细胞的应答。
Front Cell Infect Microbiol. 2021 May 25;11:676183. doi: 10.3389/fcimb.2021.676183. eCollection 2021.
6
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.形式肽受体 1(FPR1)多态性降低了局部晚期直肠癌新辅助放化疗(CCRT)治疗后的治疗效果和抗肿瘤免疫。
Cancer Immunol Immunother. 2021 Oct;70(10):2937-2950. doi: 10.1007/s00262-021-02894-8. Epub 2021 Mar 13.
7
Nonthermal plasma as part of a novel strategy for vaccination.非热等离子体作为疫苗接种新策略的一部分。
Plasma Process Polym. 2020 Oct;17(10):2000051. doi: 10.1002/ppap.202000051. Epub 2020 Jul 13.
8
Harnessing the Immunomodulatory Properties of Bacterial Ghosts to Boost the Anti-mycobacterial Protective Immunity.利用细菌体的免疫调节特性来增强抗分枝杆菌的保护性免疫。
Front Immunol. 2019 Nov 22;10:2737. doi: 10.3389/fimmu.2019.02737. eCollection 2019.
9
IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Infection.IL-17RA 信号在感染过程中调节 CD8+T 细胞的存活和耗竭。
Front Immunol. 2018 Oct 11;9:2347. doi: 10.3389/fimmu.2018.02347. eCollection 2018.
10
Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.人外周血单核细胞感染结核分枝杆菌 H37Ra 后的免疫反应特征:供体申报的卡介苗接种史对免疫反应和结核分枝杆菌生长的影响。
PLoS One. 2018 Sep 11;13(9):e0203822. doi: 10.1371/journal.pone.0203822. eCollection 2018.
病原体诱导的促凋亡表型和高 CD95(Fas)表达伴随着不理想的 CD8+T 细胞反应:腺病毒疫苗的逆转。
PLoS Pathog. 2012;8(5):e1002699. doi: 10.1371/journal.ppat.1002699. Epub 2012 May 17.
4
Notch controls the magnitude of T helper cell responses by promoting cellular longevity.Notch 通过促进细胞长寿来控制辅助性 T 细胞反应的幅度。
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9041-6. doi: 10.1073/pnas.1206044109. Epub 2012 May 21.
5
Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.痘苗病毒 14K 蛋白的佐剂样作用:以环子孢子蛋白为基础的疟疾疫苗的案例研究。
J Immunol. 2012 Jun 15;188(12):6407-17. doi: 10.4049/jimmunol.1102492. Epub 2012 May 21.
6
Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.猪细小病毒样颗粒与表达疟原虫 CS 的痘苗病毒载体联合对疟疾的疫苗效力。
PLoS One. 2012;7(4):e34445. doi: 10.1371/journal.pone.0034445. Epub 2012 Apr 17.
7
Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation.组织驻留记忆 T(TRM)细胞在不存在持续局部抗原呈递的情况下实现长寿命上皮免疫。
Proc Natl Acad Sci U S A. 2012 May 1;109(18):7037-42. doi: 10.1073/pnas.1202288109. Epub 2012 Apr 16.
8
Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues.抗原非依赖性分化和组织中效应样驻留记忆 T 细胞的维持。
J Immunol. 2012 May 15;188(10):4866-75. doi: 10.4049/jimmunol.1200402. Epub 2012 Apr 13.
9
Distinct effects of saracatinib on memory CD8+ T cell differentiation.沙卡替尼对记忆性 CD8+T 细胞分化的独特作用。
J Immunol. 2012 May 1;188(9):4323-33. doi: 10.4049/jimmunol.1101439. Epub 2012 Mar 26.
10
Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection.效应记忆 CD8(+) T 细胞的病毒抑制活性决定了疫苗突破感染后接种猴子中的猴免疫缺陷病毒载量。
J Virol. 2012 May;86(10):5877-84. doi: 10.1128/JVI.00315-12. Epub 2012 Mar 14.